1. Home
  2. MNKD vs MBIN Comparison

MNKD vs MBIN Comparison

Compare MNKD & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • MBIN
  • Stock Information
  • Founded
  • MNKD 1991
  • MBIN 1990
  • Country
  • MNKD United States
  • MBIN United States
  • Employees
  • MNKD N/A
  • MBIN N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • MBIN Major Banks
  • Sector
  • MNKD Health Care
  • MBIN Finance
  • Exchange
  • MNKD Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • MNKD 1.8B
  • MBIN 2.1B
  • IPO Year
  • MNKD 2004
  • MBIN 2017
  • Fundamental
  • Price
  • MNKD $6.22
  • MBIN $37.44
  • Analyst Decision
  • MNKD Strong Buy
  • MBIN Buy
  • Analyst Count
  • MNKD 5
  • MBIN 3
  • Target Price
  • MNKD $8.40
  • MBIN $53.83
  • AVG Volume (30 Days)
  • MNKD 2.8M
  • MBIN 126.4K
  • Earning Date
  • MNKD 11-07-2024
  • MBIN 01-27-2025
  • Dividend Yield
  • MNKD N/A
  • MBIN 0.96%
  • EPS Growth
  • MNKD N/A
  • MBIN 16.58
  • EPS
  • MNKD 0.08
  • MBIN 6.03
  • Revenue
  • MNKD $267,200,000.00
  • MBIN $607,406,000.00
  • Revenue This Year
  • MNKD $45.36
  • MBIN N/A
  • Revenue Next Year
  • MNKD $16.99
  • MBIN $3.04
  • P/E Ratio
  • MNKD $74.80
  • MBIN $6.22
  • Revenue Growth
  • MNKD 51.35
  • MBIN 25.90
  • 52 Week Low
  • MNKD $3.17
  • MBIN $35.56
  • 52 Week High
  • MNKD $7.63
  • MBIN $53.27
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.90
  • MBIN 38.78
  • Support Level
  • MNKD $5.81
  • MBIN $37.15
  • Resistance Level
  • MNKD $6.77
  • MBIN $39.49
  • Average True Range (ATR)
  • MNKD 0.25
  • MBIN 0.90
  • MACD
  • MNKD -0.07
  • MBIN -0.19
  • Stochastic Oscillator
  • MNKD 36.44
  • MBIN 12.71

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

Share on Social Networks: